Artiva Biotherapeutics, Inc. (ARTV) Earnings Per Share (EPS)
Artiva Biotherapeutics, Inc. (ARTV) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2022-12-31 | -$76.67 |
| 2023-12-31 | -$35.78 |
| 2024-12-31 | -$5.81 |
| 2025-12-31 | -$3.43 |
How ARTV compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc. | -$3.17 |
| KURA | Kura Oncology Inc. | -$3.18 |
| REPL | Replimune Group Inc. | -$3.38 |
| AXSM | Axsome Therapeutics Inc. | -$3.68 |
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
These are five companies in the same sector as ARTV with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Artiva Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("ARTV")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARTV | $11.44 | -0.78% | 0.14M |
| 3 | ||||
| 4 | ||||
| 5 |